References
- Callea M, Cammarata-Scalisi F, Galeotti A, Villani A, and Valentini D. COVID-19 and Down syndrome. Acta Paediatr. 2020;109(9): 1901–1902.
- Kazemi M, Salehi M, and Kheirollahi M. Down Syndrome: Current Status, Challenges and Future Perspectives. Int J Mol Cell Med. 2016;5(3): 125–133.
- Antonarakis SE, Skotko BG, Rafii MS, Strydom A, Pape SE, Bianchi DW, et al. Down syndrome. Nat Rev Dis Primers. 2020;6(1): 9.
- De Toma I, and Dierssen M. Network analysis of Down syndrome and SARS-CoV-2 identifies risk and protective factors for COVID-19. Sci Rep. 2021;11(1): 1930.
- Illouz T, Biragyn A, Frenkel-Morgenstern M, Weiss-berg O, Gorohovski A, Merzon E, et al. Specific Susceptibility to COVID-19 in Adults with Down Syndrome. Neuromolecular Med. 2021;23(4): 561–571.
- Kantar A, Mazza A, Bonanomi E, Odoni M, Seminara M, Verde ID, et al. COVID-19 and children with Down syndrome: is there any real reason to worry? Two case reports with severe course. BMC Pediatr. 2020;20(1): 561.
- Emes D, Hüls A, Baumer N, Dierssen M, Puri S, Russell L, et al. COVID-19 in Children with Down Syndrome: Data from the Trisomy 21 Research Society Survey. Journal of Clinical Medicine. 2021; 10(21): 5125.
- Embregts P, Heerkens L, Frielink N, Giesbers S, Vromans L, and Jahoda A. Experiences of mothers caring for a child with an intellectual disability during the COVID-19 pandemic in the Netherlands. J Intellect Disabil Res. 2021;65(8): 760–771.
- Amatori S, Sisti D, Perroni F, Brandi G, Rocchi MBL, and Gobbi E. Physical activity, sedentary behaviour and screen time among youths with Down syndrome during the COVID-19 pandemic. J Intellect Disabil Res. 2022;66(12): 903–912.
- Shetty J, Shetty A, Mundkur SC, Dinesh TK, and Pundir P. Economic burden on caregivers or parents with Down syndrome children-a systematic review protocol. Syst Rev. 2023;12(1): 3.
- Sideropoulos V, Kye H, Dukes D, Samson AC, Palikara O, and Van Herwegen J. Anxiety and Worries of Individuals with Down Syndrome During the COVID-19 Pandemic: A Comparative Study in the UK. J Autism Dev Disord. 2023;53(5): 2021–2036.
- Rubenstein E, Kyprianou N, Kumar PS, Kriova AM, Sokoloff A, Hillerstrom H, et al. Healthcare and Behavior Changes for Adults With Down Syndrome 1-Year Into COVID-19. Am J Intellect Dev Disabil. 2023;128(4): 273–281.
- Meguid NA, Nashaat NH, Abdallah HR, Hemimi M, Elnahry A, El-Hariri HM, et al. Influence of COVID-19 pandemic lockdown on a sample of Egyptian children with Down syndrome. Egypt J Med Hum Genet. 2022;23(1): 68.
- Santoro SL, Baker S, Blake JM, Cabrera MJ, Caughman K, Chung J, et al. Views on the impact of the COVID-19 pandemic on health in people with Down syndrome from diverse backgrounds. Am J Med Genet A. 2023;191(8): 2045–2056.
- Fujino H, and Itai M. Disinfection behavior for COVID-19 in individuals with Down syndrome and caregivers’ distress in Japan: a cross-sectional retrospective study. J Dev Phys Disabil. 2023;35(1): 81–96.
- Pagnamenta E, Hodgkinson P, Davidson R, and Joffe VL. The impact of COVID-19 (Coronavirus) on children and young people with Down syndrome in the United Kingdom. Front Psychol. 2023;14: 1175636.
- Hartley SL, Fleming V, Piro-Gambetti B, Cohen A, Ances BM, Yassa MA, et al. Impact of the COVID-19 pandemic on daily life, mood, and behavior of adults with Down syndrome. Disabil Health J. 2022;15(3): 101278.
- Hüls A, Feany PT, Zisman SI, Costa ACS, Dierssen M, Balogh R, et al. COVID-19 Vaccination of Individuals with Down Syndrome—Data from the Trisomy 21 Research Society Survey on Safety, Efficacy, and Factors Associated with the Decision to Be Vaccinated. Vaccines. 2022; 10(4): 530.
- Viner RM, Mytton OT, Bonell C, Melendez-Torres GJ, Ward J, Hudson L, et al. Susceptibility to SARS-CoV-2 Infection Among Children and Adolescents Compared With Adults: A Systematic Review and Meta-analysis. JAMA Pediatr. 2021;175(2): 143–156.
- Turk MA, Landes SD, Formica MK, and Goss KD. Intellectual and developmental disability and COVID-19 case-fatality trends: TriNetX analysis. Disabil Health J. 2020;13(3): 100942.
- Pierce CA, Preston-Hurlburt P, Dai Y, Aschner CB, Cheshenko N, Galen B, et al. Immune responses to SARS-CoV-2 infection in hospitalized pediatric and adult patients. Sci Transl Med. 2020;12(564): eabd5487.
- Yoshida M, Worlock KB, Huang N, Lindeboom RGH, Butler CR, Kumasaka N, et al. Local and systemic responses to SARS-CoV-2 infection in children and adults. Nature. 2022;602(7896): 321–327.
- Hatch-Stein JA, Zemel BS, Prasad D, Kalkwarf HJ, Pipan M, Magge SN, et al. Body Composition and BMI Growth Charts in Children With Down Syndrome. Pediatrics. 2016;138(4): e20160541.
- Newman AM, Jhaveri R, Patel AB, Tan TQ, Toia JM, and Arshad M. Trisomy 21 and Coronavirus Disease 2019 in Pediatric Patients. J Pediatr. 2021228: 294–296.
- Pinku H, Hüls A, Feany PT, Baumer N, Dierssen M, Bargagna S et al. Differences in clinical presentation, severity, and treatment of COVID-19 among individuals with Down syndrome from India and high-income countries: Data from the Trisomy 21 Research Society survey. J Glob Health. 2022;12: 05035
- Santoro M, Coi A, Spadoni I, Bianchi F, and Pierini A. Sex differences for major congenital heart defects in Down Syndrome: A population based study. Eur J Med Genet. 2018;61(9): 546–550.
- Pfitzer C, Helm PC, Rosenthal LM, Berger F, Bauer UMM, and Schmitt KR. Dynamics in prevalence of Down syndrome in children with congenital heart disease. Eur J Pediatr. 2018;177(1): 107–115.
- Krishnan US, Krishnan SS, Jain S, Chavolla-Calderon MB, Lewis M, Chung WK, et al. SARS-CoV-2 Infection in Patients with Down Syndrome, Congenital Heart Disease, and Pulmonary Hypertension: Is Down Syndrome a Risk Factor? J Pediatr. 2020;225: 246–248.
- Hamulka J, Jeruszka-Bielak M, Górnicka M, Drywień ME, and Zielinska-Pukos MA. Dietary Supplements during COVID-19 Outbreak. Results of Google Trends Analysis Supported by PLifeCOVID-19 Online Studies. Nutrients. 2020;13(1): 54.
- Ani C, Grantham-McGregor S, and Muller D. Nutritional supplementation in Down syndrome: theoretical considerations and current status. Dev Med Child Neurol. 2000;42(3): 207–13.
- Docherty AB, Harrison EM, Green CA, Hardwick HE, Pius R, Norman L, et al. Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study. BMJ. 2020;369: m1985.
- Latos-Bieleńska A, Marcus E, Jamry-Dziurla A, Rankin J, Barisic I, Cavero-Carbonell C, et al. 2022, ‘COVID-19 and children with congenital anomalies: a European survey of parents’ experiences of healthcare services, BMJ Open. 2022. 12(7): e061428.